Abstract
Although vitamin D insufficiency is related to inferior prognosis in some cancers, limited data exist in hematologic malignancies. We evaluated the relationship between 25(OH)D serum levels and time to first treatment (TFT), a disease-specific end point, in 130 previously untreated Binet stage A chronic lymphocytic leukemia (CLL) patients. Measurement of 25(OH)D was performed by means of a direct, competitive chemiluminescence immunoassay using the DiaSorin LIAISON 25(OH)D TOTAL assay (DiaSorin, Inc., Stillwater, Minnesota). Overall, 41 patients (31.5%) had severe vitamin D insufficiency (
Original language | English |
---|---|
Pages (from-to) | 443-447 |
Number of pages | 5 |
Journal | Leukemia Research |
Volume | 36 |
Issue number | 4 |
DOIs | |
Publication status | Published - Apr 2012 |
Keywords
- Clinical outcome
- CLL
- Prognostic variables
- Vitamin D
ASJC Scopus subject areas
- Cancer Research
- Hematology
- Oncology